Olgu Sunumu
Yıl 2020,
Cilt: 42 Sayı: 4, 507 - 511, 31.12.2020
Öz
Kaynakça
- Hassan S, Sheikh F, Jamal S, Ezeh J, Akhtar A. Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment. Cureus. 2020;.
- Giannis D, Ziogas I, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. Journal of Clinical Virology. 2020;127:104362.
- Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V et al. Hypercoagulability of COVID‐19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis. Journal of Thrombosis and Haemostasis. 2020;.
- Jose R, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. The Lancet Respiratory Medicine. 2020;8(6):e46-e47.
- Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M et al. The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome. Journal of Thrombosis and Haemostasis. 2020;.
- Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E et al. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Thrombosis and Haemostasis. 2020;120(06):998-1000.
- Connors J, Levy J. Thromboinflammation and the hypercoagulability of COVID‐19. Journal of Thrombosis and Haemostasis. 2020;.
- Levi M, Thachil J, Iba T, Levy J. Coagulation abnormalities and thrombosis in patients with COVID-19. The Lancet Haematology. 2020;7(6):e438-e440.
- Mumm J, Osterman A, Ruzicka M, Stihl C, Vilsmaier T, Munker D et al. Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis?. European Urology. 2020;.
- Pei G, Zhang Z, Peng J, Liu L, Zhang C, Yu C et al. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. Journal of the American Society of Nephrology. 2020;31(6):1157-1165.
Yıl 2020,
Cilt: 42 Sayı: 4, 507 - 511, 31.12.2020
Öz
In the same family, the SARS-COV-2 virus is more virulent than the other virus, and it is known in many patients that it causes extreme symptoms ranging from high-grade fever, cough, dyspnea, to gastrointestinal and hematological symptoms.
The extreme inflammatory state secondary to Covid‐19 may lead to a severe imbalance in hemostasis as found recently in a condition of disseminated intravascular coagulation (DIC) and consumption coagulopathy, identified as decreased platelet count, increased fibrin or fibrinogen and red blood cells destruction which growing ferritin.
The virus has the ability to cause red blood cell hemolysis even if the blood is inside the EDTA tube, which reflects the virulent traits of the virus and its non-understandable pathogenesis, which is still suspected.
The damage caused by the tissue may increase the level of lactic acid dehydrogenase and may be an indicator of the amount of damage caused by the disease in the organs of the body.
Anahtar Kelimeler
COVID-19 Blood coagulation EDTA tube Ferritin Lactic Acid Dehydrogenase
Kaynakça
- Hassan S, Sheikh F, Jamal S, Ezeh J, Akhtar A. Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment. Cureus. 2020;.
- Giannis D, Ziogas I, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. Journal of Clinical Virology. 2020;127:104362.
- Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V et al. Hypercoagulability of COVID‐19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis. Journal of Thrombosis and Haemostasis. 2020;.
- Jose R, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. The Lancet Respiratory Medicine. 2020;8(6):e46-e47.
- Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M et al. The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome. Journal of Thrombosis and Haemostasis. 2020;.
- Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E et al. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Thrombosis and Haemostasis. 2020;120(06):998-1000.
- Connors J, Levy J. Thromboinflammation and the hypercoagulability of COVID‐19. Journal of Thrombosis and Haemostasis. 2020;.
- Levi M, Thachil J, Iba T, Levy J. Coagulation abnormalities and thrombosis in patients with COVID-19. The Lancet Haematology. 2020;7(6):e438-e440.
- Mumm J, Osterman A, Ruzicka M, Stihl C, Vilsmaier T, Munker D et al. Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis?. European Urology. 2020;.
- Pei G, Zhang Z, Peng J, Liu L, Zhang C, Yu C et al. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. Journal of the American Society of Nephrology. 2020;31(6):1157-1165.
Toplam 10 adet kaynakça vardır.
Ayrıntılar
| Birincil Dil | İngilizce |
|---|---|
| Konular | Sağlık Kurumları Yönetimi |
| Bölüm | Case Reports |
| Yazarlar | |
| Yayımlanma Tarihi | 31 Aralık 2020 |
| Kabul Tarihi | 8 Aralık 2020 |
| Yayımlandığı Sayı | Yıl 2020Cilt: 42 Sayı: 4 |